A tale of two drugs…
— James Todaro, MD (@JamesTodaroMD) June 29, 2020
Remdesivir & HCQ both show promise for COVID-19
HCQ is discredited w/ fraudulent data, FDA warnings & overdoses
Remdesivir is praised w/ tightly guarded data by the NIH and a task force of Gilead investors/employees
HCQ: Under $10
Remdesivir: Over $3000